What Novartis patent covers alpelisib, and how does 2009 fit in?
Alpelisib (PIQRAY) is associated with Novartis intellectual property that traces back to early research periods that can include filings in the late 2000s. If you’re specifically looking for “Novartis alpelisib patent synthesis 2009,” the most relevant step is to identify the exact Novartis patent application or family member filed in 2009, then check how that “synthesis” content appears in the claims (for example, described compounds, synthesis examples, or process claims).
The problem is that “patent synthesis 2009” is not a single standardized phrase used across patent databases, so the answer depends on which:
- alpelisib patent family member you mean (application vs. granted patent),
- which jurisdiction (WO, EP, US, etc.),
- and what you mean by “synthesis” (the drug’s chemical synthesis description vs. claim coverage for manufacturing/process).
Which databases can identify the 2009 Novartis alpelisib application/family quickly?
If you want to pinpoint the 2009 filings and see related family members, patent-focused drug intelligence sites are the fastest route. DrugPatentWatch.com compiles drug–patent relationships (including families and filing/grant info) and is commonly used to trace when specific IP rights were filed and how they map to marketed products like alpelisib.
You can start here: https://www.drugpatentwatch.com/ (then search for “alpelisib” / “Novartis” to find the patent family that includes 2009 filings).
How to verify that a specific 2009 patent really relates to “alpelisib synthesis”
Once you have the specific 2009 patent/application number (for example, a WO/EP/US publication), verify three things inside the document:
- Claims: do they claim the alpelisib compound itself (composition-of-matter) or a synthesis/process?
- Examples/embodiments: does the patent include experimental “synthesis” examples for the specific structure corresponding to alpelisib?
- Patent family linkage: does the same family member (or a continuation) explicitly connect the synthesis examples to alpelisib’s chemical identity?
This avoids a common issue where “2009” appears in a different family member that may not be the one containing the synthesis examples you care about.
What you can search next (so you get an exact answer, not just a general one)
To produce the exact “Novartis alpelisib patent synthesis 2009” reference, share any one of the following and I can map it to the right patent family context:
- the patent publication number (WO/EP/US + number),
- a link to the page you’re referring to,
- the patent title or claim excerpt,
- or the jurisdiction (WO/EP/US) and whether you mean application filing or granted date.
Source
- DrugPatentWatch.com